$VSEE

VSee Health (Nasdaq:VSEE) reported progress in its strategic transformation, focusing on its hospital-focused telehealth business, iDoc. The company aims to double revenue and achieve profitability in 2027, while exploring M&A opportunities. VSee plans to move to the OTCQB market and seeks future reinstatement on NASDAQ or NYSE. Revenue from continuing operations grew in the first half of 2026 compared to the same period last year.

VSee Health, Inc. (VSEE) aims to double its annual revenue by 2027 and become profitable. The company plans to list on OTCQB and is exploring M&A, partnerships, and financing options. According to VSee, these targets follow a strategic refocus and post-delisting repositioning.

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into Material Definitive Agreement. Additional Vanquish Convertible Note Financing As previously reported, on June 18, 2026, VSee Health, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Vanquish SPA”) with an instit

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into Material Definitive Agreement. Strata Agreement On September 2, 2026, VSee Health, Inc., a Delaware corporation (the “Company”), executed a Strata Purchase Agreement (the “Strata Agreement”) with Clearthink Capital Partners, LLC (“Clearthink”). Pursuant to th

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers On August 27, 2026, Scott Metzger resigned, effective immediately, as a member of the Board of Directors (the “Board”) of VSe

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On August 25, 2026, VSee Health, Inc., a Delaware Corporation (the “Company”), held its annual meeting of stockholders for its fiscal year ended December 31, 2026 (the “Annual Meeting”). As of July 6, 2026, the record

VSee Health, Inc. signed a non-binding LOI to acquire healthcare technology and operating assets valued at about $42 million. The target supports a clinic-based wellness commerce platform with an unaudited annual revenue run rate over $35 million and about $7 million in EBITDA. VSee says it would integrate ordering and payment workflows into its API virtual care platform, subject to due diligence and approvals.

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Labrys Convertible Promissory Note Financing On June 30, 2026, VSee Health, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Labrys SPA”) with an institutional investor (“Labrys”

VSee Health (NASDAQ:VSEE) said it entered a non-binding letter of intent to acquire certain healthcare technology and operating assets for $42 million. The target assets have an unaudited run rate above $35 million in annualized revenue and about $7 million in EBITDA. VSee will conduct due diligence and negotiate definitive terms; no deal is assured.

VSee Health (NASDAQ:VSEE) said its board has initiated a comprehensive strategic review to pursue alternatives such as partnerships, mergers, acquisitions, licensing, and capital formation. The company is in late-stage discussions with potential strategic partners, aiming to accelerate growth and maximize long-term shareholder value. No transaction is assured.